WO2022185063A1 - A catheter - Google Patents
A catheter Download PDFInfo
- Publication number
- WO2022185063A1 WO2022185063A1 PCT/GB2022/050562 GB2022050562W WO2022185063A1 WO 2022185063 A1 WO2022185063 A1 WO 2022185063A1 GB 2022050562 W GB2022050562 W GB 2022050562W WO 2022185063 A1 WO2022185063 A1 WO 2022185063A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- catheter
- component
- catheter according
- cardiovascular device
- exchangeable
- Prior art date
Links
- 230000002526 effect on cardiovascular system Effects 0.000 claims abstract description 93
- 210000004204 blood vessel Anatomy 0.000 claims abstract description 53
- 230000005291 magnetic effect Effects 0.000 claims description 59
- 210000003709 heart valve Anatomy 0.000 claims description 41
- 230000008878 coupling Effects 0.000 claims description 13
- 238000010168 coupling process Methods 0.000 claims description 13
- 238000005859 coupling reaction Methods 0.000 claims description 13
- 239000003302 ferromagnetic material Substances 0.000 claims description 9
- 238000006073 displacement reaction Methods 0.000 claims description 5
- 230000001419 dependent effect Effects 0.000 claims 1
- 238000000034 method Methods 0.000 description 19
- 239000011248 coating agent Substances 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 238000001356 surgical procedure Methods 0.000 description 6
- 238000004873 anchoring Methods 0.000 description 5
- 206010002906 aortic stenosis Diseases 0.000 description 5
- 210000000709 aorta Anatomy 0.000 description 4
- 210000001765 aortic valve Anatomy 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000000654 additive Substances 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000004593 Epoxy Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000007767 bonding agent Substances 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000005294 ferromagnetic effect Effects 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 239000006247 magnetic powder Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000002788 crimping Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 208000018578 heart valve disease Diseases 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000002324 minimally invasive surgery Methods 0.000 description 1
- 210000004115 mitral valve Anatomy 0.000 description 1
- 210000003102 pulmonary valve Anatomy 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 239000012781 shape memory material Substances 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 210000000591 tricuspid valve Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2002/9528—Instruments specially adapted for placement or removal of stents or stent-grafts for retrieval of stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/009—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof magnetic
Definitions
- This invention relates to a catheter.
- a catheter for retrieving a cardiovascular device such as a heart valve, from within a blood vessel.
- Valvular Heart Disease relates to diseases which hinder the function of heart valves, such as Aortic Stenosis, in which the aortic valve becomes calcified and narrowed over time, thereby losing its ability to function.
- Aortic stenosis is common in the elderly. With increasing life expectancy, the prevalence of Aortic Stenosis represents a growing health problem.
- Aortic Stenosis can be treated by either major open heart surgery called surgical aortic valve replacement (SAVR) or, increasingly, a keyhole procedure called transcatheter aortic valve implantation (TAVI).
- SAVR surgical aortic valve replacement
- TAVI transcatheter aortic valve implantation
- SAVR the stenosed aortic valve is excised, and a replacement is sutured in its place.
- TAVI by contrast, is a minimally invasive procedure in which a replacement valve is deployed via a catheter and positioned and expanded inside the diseased valve without excising the diseased valve.
- TAVI was initially developed and approved for use in aortic stenosis patients who were deemed too high risk to be able to survive SAVR.
- TAVI valve-in-valve procedure is increasingly becoming the default option.
- TAVI valves are also subject to degeneration and failure over time. Treatment for such cases is also most likely to be TAVI- in-TAVI.
- valve-in-valve TAVI procedures for example, two, three, or more valve- in-valve TAVI procedures, reduce the effective annular area of the valve orifice each time a new valve “ring” is deployed within the previous valve structure.
- This shrinking annular area represents a predictable limitation to recurrent treatment of younger patients undergoing bioprosthetic SAVR or de novo TAVI. Given the exponential rise globally in the number of patients having these bioprostheses, a solution that prevents shrinking annulus would have a major clinical and economic impact.
- the present invention provides a catheter for retrieving a cardiovascular device, for example a heart valve, from within a blood vessel.
- the catheter comprises a retrieval module configured to magnetically engage a cardiovascular device within the blood vessel so as to disengage the cardiovascular device from the blood vessel for retrieval from within the blood vessel using the catheter.
- the present invention provides a device that can reliably and safely remove a cardiovascular device, for example a replacement heart valve component, that is failing due to wear over time.
- the retrieval module may comprise a ferromagnetic material.
- the ferromagnetic material may act to disengage the cardiovascular device from the holding member through magnetic attraction.
- the cardiovascular device may comprise a permanent magnet. This advantageously provides a passive retrieval module to disengage the cardiovascular device from the blood vessel.
- the retrieval module may comprise one or more permanent magnets.
- the retrieval module may comprise an electromagnet operable to generate a magnetic force.
- the magnetic force can act to disengage the cardiovascular device from the blood vessel.
- the cardiovascular device may comprise a ferromagnetic material and/or a permanent magnet.
- the electromagnet may be operable by a user, for example the electromagnet may be remotely operable, for example by an operator using a switch.
- the switch may be operatively connected to the retrieval module via wired or wireless communication means.
- the electromagnet may be configured to generate a variable magnetic force, for example by operatively connecting the retrieval module to a controlled power source.
- the retrieval module may be connectable to an external power source.
- the catheter may further comprise one or more gripping elements, for example a barbed member, arranged to secure the disengaged cardiovascular device to the catheter.
- the one or more gripping elements may secure the disengaged cardiovascular device to the catheter such that the cardiovascular device is removed from the patient with the catheter.
- the catheter may further comprise a sheath slidably connected to the catheter and arranged to receive the disengaged cardiovascular device.
- the sheath may be configured to at least partially, for example substantially or completely, surround the disengaged cardiovascular device.
- the sheath may be arranged to compress the retrieved cardiovascular device in a radial direction upon receipt of the retrieved cardiovascular device.
- the sheath can crimp or crush the cardiovascular device upon receipt of the cardiovascular device therein. Crimping or crushing the cardiovascular device reduces the size of the cardiovascular device for extraction.
- the sheath may comprise a tapered profile.
- the sheath may be located at a proximal position along the catheter relative to the retrieval module. Sliding the tapered sheath in a distal direction can cause the cardiovascular device to be crimped or crushed.
- the catheter may comprise displacement means for moving at least part of the retrieval module in a radial direction.
- the radial direction may be a radially outward direction. This advantageously allows the retrieval module to be brought into closer proximity with the cardiovascular component within the blood vessel to facilitate the disengagement of the cardiovascular device and the blood vessel.
- the radial displacement of the retrieval module can facilitate engagement between the retrieval module and the cardiovascular device.
- the cardiovascular device may be a replacement heart valve component.
- the magnetic coupling may be configured to disengage the replacement heart valve component from a holding member arranged to hold the replacement heart valve component within the blood vessel.
- the catheter may further comprise a deployment module arranged to deploy a second cardiovascular device within the blood vessel.
- the second cardiovascular device may thereby be anchored within the blood vessel.
- the second cardiovascular device may be a replacement heart valve component.
- the replacement heart valve component may, for example, be a new exchangeable replacement part for replacing the failing exchangeable replacement part.
- the deployment module may be located at a distal position along the catheter relative to the retrieval module.
- the deployment module may comprise an electromagnet operable to generate a magnetic force.
- the electromagnet may be operable to urge, for example push, a magnetic portion of the second cardiovascular device in a radial direction away from the deployment module, for example to cause engagement of the second cardiovascular device with the blood vessel.
- the magnetic portion of the second cardiovascular device may comprise a ferromagnetic material or a permanent magnet.
- the electromagnet may be operable to hold a self-expanding frame to the deployment module, such that when the electromagnet is deactivated the self-expanding frame will expand into position.
- the deployment module may comprise an inflatable bladder.
- the bladder may be arranged to expand and urge the second cardiovascular device in a radial direction away from the deployment module.
- the inflatable bladder may be arranged to urge the second cardiovascular device into engagement with a holding member in the blood vessel.
- the self-expanding frame may be made using additive manufacturing processes.
- the catheter may comprise the second cardiovascular device.
- the second cardiovascular device may be secured to the deployment module, for example, in a pre deployed configuration.
- the catheter, in particular the deployment module may comprise a second sheath for housing the second cardiovascular device.
- the second sheath may be slidably connected to the catheter.
- the second sheath may be arranged to slide along the catheter to expose the second cardiovascular device to the blood vessel.
- the second replacement heart valve component may comprise a second magnetic portion for engaging with a corresponding magnetic portion of a holding member within the blood vessel.
- the present invention provides a kit of parts comprising a catheter as described above and a cardiovascular device for use with the catheter described above.
- a replacement heart valve component for deployment using the catheter and the deployment module described above.
- the replacement heart valve component may comprise a magnetic portion, for example a ferromagnetic material or a permanent magnet, arranged such that the deployment module described above can urge the replacement heart valve component away from the catheter and into position.
- the replacement heart valve may be configured to engage with a holding member in the blood vessel to secure the replacement heart valve to the blood vessel. In other examples, the replacement heart valve may directly engage the blood vessel when deployed.
- valve implant comprising a holding member configured to be secured, for example sutured, into a patient’s aortic root, and a replaceable heart valve component configured to engage the holding member to be held within the blood vessel.
- the holding member and the replacement heart valve component are magnetically couplable.
- an exchangeable cardiovascular device comprising a magnetic portion for magnetically engaging a holding member and/or a retrieval module of a catheter.
- the magnetic portion of the exchangeable cardiovascular device is configured to magnetically engage a retrieval module of a catheter so that the retrieval module of the catheter disengages the exchangeable cardiovascular device from the blood vessel.
- the exchangeable cardiovascular device may be configured to engage a holding member within the blood vessel, and in such examples the magnetic portion of the exchangeable cardiovascular device may be magnetically couplable to the holding member.
- the magnetic portion of the exchangeable cardiovascular device is configured to magnetically engage a holding member in the blood vessel, and a retrieval module of a catheter for disengaging the exchangeable cardiovascular device from the holding member.
- the magnetic portion of the exchangeable cardiovascular device comprises one or more permanent magnets or electromagnets.
- the permanent magnets or electromagnets may be attached to the exchangeable cardiovascular device by chemical adhesive means, for example by a biocompatible epoxy bonding agent.
- the permanent magnets or electromagnets may additionally or alternatively be welded to the cardiovascular device.
- the permanent magnets or electromagnets may be secured to the exchangeable cardiovascular device between two skirts sutured around the outside and inside of the cardiovascular device.
- the cardiovascular device includes a frame, such as a self-expanding frame.
- the exchangeable cardiovascular device may include one or more magnet housing structures for receiving one or more permanent magnets or electromagnets.
- the permanent magnets or electromagnets may be secured within the magnet housing structure using a mechanical connection, such as a snap fit connection.
- the exchangeable cardiovascular device includes a magnetic coating to define a magnetic portion.
- the magnetic coating is preferably applied to specific regions of the cardiovascular device after the frame is manufactured.
- the magnetic coating may include any of a magnetic powder or a ferromagnetic powder.
- the exchangeable cardiovascular component comprises a replacement valve component having an arrangement of leaflets secured thereto.
- FIG. 1 Further aspects provide a holding member for securing an exchangeable cardiovascular component to a blood vessel.
- the exchangeable cardiovascular component is secured to the holding member by an outward radial force exerted by the exchangeable cardiovascular device.
- the holding member secures the exchangeable cardiovascular device via a magnetic coupling, for example via magnetised bands on the holding member. Additionally or alternatively to the magnetised bands, the holding member can include individual magnets for coupling with the exchangeable cardiovascular device.
- the holding member While it is preferable to secure the holding member and the exchangeable cardiovascular device by a magnetic coupling, it would be apparent that this was not essential and that the exchangeable cardiovascular device may be secured to the holding member using mechanical means, such as one or more inter-engaging mechanical elements located on the holding member and/or the exchangeable cardiovascular device.
- the holding member includes an electromagnet to hold the exchangeable cardiovascular device thereto. Including an electromagnet in the holding member provides enhanced anchoring and controllable release of the failing exchangeable component.
- Figure 1 illustrates an exemplary catheter
- Figure 2 illustrates a cross-sectional view of an aortic root with a part of a replacement heart valve secured thereto;
- Figure 3 illustrates an exemplary replacement heart valve
- Figure 4 illustrates a perspective view of an exemplary catheter within an aortic root
- Figure 5 illustrates a perspective view of a further exemplary catheter
- Figures 6A to 6H illustrates an exemplary method of using a catheter according to the present disclosure
- Figure 7 illustrates a further exemplary catheter
- Figure 8 illustrates an exemplary retrieval module.
- Figure 1 discloses an exemplary catheter 100 having an elongate body 102 extending from a proximal end 105 to a distal end 110 and including a retrieval module 115.
- the catheter 100 is inserted into a patient’s blood vessel with the distal end 110 being passed into the blood vessel and the proximal end 105 being accessible to an operator for controlling the catheter 100.
- a retrieval sheath 50 is also shown slidably secured to the body 102.
- the sheath 50 has a neck portion 52 at a proximal end of the retrieval sheath 50 and a conical portion 54 defining an opening 56 for receiving a failing exchangeable part 30 of the replacement heart valve as explained below.
- FIG 2 shows an aortic root 10 where the native diseased valve has been excised and only a lip 12 of the native aortic root remains. Also shown in Figure 2, the native valve is replaced with a replacement heart valve (only part of the replacement heart valve is shown in Figure 2 for clarity).
- the replacement heart valve is a two-part component with a permanent component 20 and an exchangeable component 30, which is illustrated in Figure 3.
- the exchangeable component 30 is releasably secured to the permanent component 20.
- the permanent component 20 is secured within the patient and acts as a holding member that holds the exchangeable component 30 in place, as described below.
- the permanent component 20 is shown secured to the aortic root 10 in close proximity to the lip 12 of tissue. However, it would be apparent this was not essential.
- the permanent component 20 has a collar 22 that engages the lip 12 which works with the expansile force of a self-expanding frame of the permanent component 20 to anchor the replacement heart valve within the aortic root 10.
- the permanent component 20 also defines an inner region 24 against which the exchangeable component 30 is held. While the permanent component 20 is shown attached to the aortic root 10, in some cases, such as where a patient can’t undergo surgery but who would benefit from an exchangeable valve in the future, it may be desirable to implant the permanent component 20 in the aortic annulus using a transcatheter valve-in-valve approach. In this case, the permanent component 20 would be secured to an existing replacement heart valve (not shown).
- the permanent component 20 may comprise a frame that can be implanted in the aorta at the aortic root 10.
- the permanent component 20 can be a self-expanding frame or a frame that can be expanded by an expanding balloon.
- the permanent component 20 can be deployed into a native diseased valve either before or simultaneously with the deployment of the exchangeable component 30 illustrated in Figure 3. Where the permanent component 20 is deployed before the deployment of the exchangeable component 30 this can be achieved using a separate catheter to the one used to deploy the exchangeable component 30.
- the exchangeable component 30 is deployed directly against the native diseased aortic root 10 and anchored thereto by the radially expanding force of a self-expanding frame 32 of the exchangeable component 30.
- the exchangeable component 30 is deployed directly against an existing bio-prosthetic replacement valve and is anchored thereto by the radially expanding force of a self-expanding frame 32 of the exchangeable component 30.
- magnetic elements such as individual magnets or magnetic bands, may be attached to the existing bio-prosthetic valve to enable magnetic coupling with the catheter 100.
- the existing bio-prosthetic valve may be adapted to include magnetic elements in situ, or prior to implanting the valve. This may be performed using a catheter configured to attach the magnets to the bio-prosthetic valve.
- Figure 4 shows an exemplary replacement heart valve with a permanent component 20 and an exchangeable component 30 secured within the aortic root 10.
- the permanent component 20 is shown holding the exchangeable component 30 via a magnetic coupling.
- the magnetic coupling is achieved by magnets 34 secured to the exchangeable component 30 and magnetised bands 26 on the permanent component 20.
- the permanent component 20 can include individual magnets 34 for coupling with the exchangeable component 30.
- the magnets 34 may be attached to the frame by chemical adhesive means, for example by a biocompatible epoxy bonding agent.
- the magnets may additionally or alternatively be welded to the frame after manufacture.
- the magnets may be held between the frame 32 and two skirts 36A, 36B (see Figure 3) sutured around the outside and inside of the frame 32.
- the frame 32 may include magnet housing structures incorporated during an additive manufacturing process. Permanent magnets may then be pushed into the magnet housing structures and secured in position, for example using a mechanical connection such as a snap fit connection.
- the magnetic regions on the replacement heart valve includes a magnetic coating.
- the magnetic coating is preferably applied to specific regions on the frame 32 after the frame is manufactured.
- the magnetic coating may include any of a magnetic powder or a ferromagnetic powder.
- the permanent component 20 and exchangeable component 30 may be secured by the permanent component 20 using mechanical means, such as one or more inter-engaging mechanical elements located on the permanent component 20 and/or the exchangeable component 30, or by the outward radial force exerted by the exchangeable component 30.
- mechanical means such as one or more inter-engaging mechanical elements located on the permanent component 20 and/or the exchangeable component 30, or by the outward radial force exerted by the exchangeable component 30.
- magnets 34 and magnetised bands 26 is preferable, it would be apparent that this specific arrangement was not essential to the function of the catheter 100.
- the permanent component 20 includes an electromagnet to hold the exchangeable component 30 thereto. Including an electromagnet in the permanent component 20 provides enhanced anchoring and controllable release of the failing exchangeable component 30.
- the exchangeable component 30 may be axially restrained by the permanent component 20, for example by opposing lips of the permanent component 20. Accordingly, the exchangeable component 30 may not be attached to the permanent component 20, but is held in place by engagement with the permanent component 20.
- the replacement component 30 comprises one or more leaflets 38 secured to the inner skirt 36B. While three leaflets are illustrated, it would be apparent that other arrangements of leaflets could be used depending on the application.
- the exchangeable component 30 can be retrieved from within the aortic root 10 using a catheter that has been positioned in a minimally invasive manner as shown in Figure 4.
- the function of the retrieval module 115 is to magnetically engage the exchangeable component 30, such that the exchangeable part 30 is disengaged from the permanent part 20.
- the exchangeable part 30 includes a magnetic portion for engaging with the retrieval module 115 when the retrieval module 115 applies a radially inward force to the exchangeable component 30.
- the exchangeable component 30 may include any of: a ferromagnetic material, one or more magnets or one or more magnetic portions arranged to engage the retrieval module 115. The exchangeable part 30 can, therefore, be disengaged from the blood vessel wall 10 via the permanent part 20.
- the catheter 100 includes displacement means to displace the retrieval module 115 in a radially outward direction to facilitate engagement with the exchangeable component 30.
- the displacement means may include an inflatable bladder for moving one or more permanent magnets and/or additional electromagnetics in a radially outward direction to help detach the exchangeable component 30 from the wall of the blood vessel. It will be appreciated that reducing the distance between the magnets of the retrieval module 115 and the exchangeable component 30 will increase the force of the magnetic attraction and so provide a larger force to disengage the exchangeable component 30 from the blood vessel 10 and/or permanent component 20.
- the retrieval module 115 may also be operatively connected to a controllable power source (not shown) adapted to provide a variable electrical power to the electromagnet in order to generate a variable level of magnetic force.
- a controllable power source not shown
- the catheter 100 can also include an electrical connector (not shown) for connecting to an external power supply. While an electromagnet is preferable, it would be apparent that this is not essential.
- the retrieval module 115 comprises a ferromagnetic material to provide a magnetic portion so that the retrieval module 115 can function in a passive manner and cause the disengagement of the exchangeable component 30 without requiring external power.
- the catheter 100 in particular the retrieval module 115, may include magnets and/or electromagnets 140 mounted on a self-expanding frame 130 which can be unsheathed to expand when in close proximity to the permanent component 20.
- This frame 130 can then be controllably collapsed, for example by pulling on wires 135 connected to the magnets 140 and/or the frame 130, when magnetic engagement to the exchangeable part 30 is achieved.
- the wire 135 may be a power cable for the electromagnets 140.
- the wire 135 may act as a tensile element while providing an electrical connection from the electromagnet 140 to the power source (not shown) connected to the proximal end of the catheter 100.
- the retrieval module 115 may collapse the self-expanding frame 130 using magnet forces alternatively or in addition to the mechanical means.
- the catheter 100 illustrated in Figures 7 and 8 may also include a deployment module 120 having a new exchangeable valve 40 that can be unsheathed in the manner described below.
- the exchangeable component 30 is retained on the catheter 100 after it has been disengaged from the permanent component 20 or blood vessel 10 by the magnet or electromagnet.
- the exchangeable component 30 may be retained on the catheter 100 by the magnet or electromagnet that acts to hold the exchangeable component 30 on the catheter 100.
- the magnet or electromagnet acts to collapse the exchangeable component 30 against the body 102.
- the retrieval sheath 50 may be slid over the collapsed exchangeable component 30 to cover it and facilitate extraction of the catheter 100 and exchangeable component 30.
- the retrieval module 115 includes a gripping element, such as a barbed member (not shown), for gripping the retrieved exchangeable component 30 against the body 102. This provides a further means for retaining the retrieved exchangeable component 30 when retrieving the catheter 100 from the patient.
- a gripping element such as a barbed member (not shown)
- Figure 5 illustrates an alternative exemplary catheter with a body 102, a retrieval module 115, a retrieval sheath 50 and a deployment module 120.
- the functional and structural aspects of the catheter body 102, the retrieval sheath 50 and the retrieval module 115 are the same as those described in relation to the catheter 100 illustrated in Figures 1, 4, 7 and 8.
- the deployment module 120 illustrated in Figure 5 is used to deploy a replacement exchangeable component 40 once the old or failing exchangeable component 30 has been removed from the permanent component 20.
- the illustrated deployment module 120 also includes a deployment sheath 42 for holding the replacement exchangeable component 40 on the body 102 until it is needed. While a deployment module 120 is advantageous, it is not essential to the function of the retrieval module 115. Similarly, a catheter may be provided having a deployment module 120 without a retrieval module 115.
- the exchangeable component 30 can be deployed using a standard delivery system, or an adapted system when deployed in a coupled configuration with a permanent component 20 as described in the present application.
- a catheter including both a retrieval module 115 and deployment module 120 advantageously removes the need for performing the steps of removing the catheter 100 with the failing exchangeable component 30 from the patient and then inserting a further catheter with the replacement exchangeable component 40 into the patient, as the replacement exchangeable component 40 is conveyed to the implant site at the same time as the retrieval module 115. It would be apparent it is not necessary to remove the first catheter with the failing exchangeable component 30 before inserting the second catheter with the replacement exchangeable component 40, and that in some cases, it will be advantageous to simultaneously deploy both catheters. For example the two catheters may be deployed through each femoral artery.
- the deployment module 120 preferably deploys the replacement exchangeable component 40 using magnetic means, for example using an electromagnet arranged to exert a radially outward magnetic force on the replacement exchangeable component 40 such that the replacement exchangeable component 40 is urged towards the permanent component 20.
- the exchangeable component 40 preferably includes an expanding frame 32 which opens and achieves secure engagement with the permanent component 20 so that the permanent component 20 holds the replacement exchangeable component 40 in place.
- the replacement exchangeable component 40 includes an array of magnets for engaging with the magnetic bands 26 of the permanent component 20.
- the expansion of the replacement exchangeable part 40 can be aided by the magnetic attraction between the magnetic bands 26 on the permanent component and the arrays of magnets on the replacement exchangeable component 40, and the radially outward force of the electromagnet of the deployment module 120. It would be apparent that when the replacement exchangeable component 40 is held by the permanent component 20 by a magnetic coupling, the anchoring forces holding the replacement exchangeable component 40 to the permanent component 20 can be used to enhance an anchoring force provided by the contact between the permanent component 20 and the replacement exchangeable component 40.
- the deployment module 120 includes an inflatable bladder or balloon (not shown) arranged to urge the replacement exchangeable component 40 towards the permanent component 20 and into engagement with the permanent component 20, such that the replacement exchangeable component 40 is held in place by the permanent component 20.
- an inflatable bladder is used to deploy the replacement exchangeable component 40
- the inflatable bladder may be arranged to press the replacement exchangeable component 40 against the permanent component 20 to secure the replacement exchangeable component 40 in position.
- the permanent component 20 and the replacement exchangeable component 40 are held together by a magnetic coupling, it is not necessary for the deployment module 120 to ensure contact between the replacement exchangeable component 40 and the permanent component 20, although this may still be achieved.
- the replacement exchangeable component 40 may comprise a self-expanding frame 32, for example comprising a shape memory material.
- the replacement exchangeable component 40 may be held on the deployment module 120 in a collapsed state by an electromagnet of the deployment module 120, and then the electromagnet can be deactivated to release the replacement exchangeable component 40.
- the self-expanding frame 32 of the replacement exchangeable component 40 may expand into contact with the permanent component 20 such that the permanent component 20 holds the replacement exchangeable component 40 in position.
- the replacement exchangeable component 40 comprises ferromagnetic material or permanent magnets to allow the electromagnet to hold the replacement exchangeable component 40 in the collapsed state.
- the catheter 100 may be provided with a deployment module 120 without a replacement exchangeable component 40 secured thereto.
- a device may be part of a kit provided to a cardiologist so that they can select the appropriate size of replacement exchangeable component 40 for attaching to the deployment module 120 in the catheter laboratory.
- the deployment module 120 may deploy the replacement exchangeable component 40 into direct contact with the blood vessel 10.
- Figures 6A to 6H illustrate an exemplary method of using the catheter 100.
- a catheter 100 having a retrieval module 115 and deployment module 120 as described above is deployed and guided into position such that the retrieval module 115 is aligned with the failing exchangeable component 30.
- This process can be aided using an imaging technique such as X-Ray imaging.
- the catheter 100 is preferably advanced into position on a guidewire through the failing exchangeable component 30 in the aortic root 10. In this position, the replacement exchangeable component 40 is sheathed on the catheter 100, and is located in the left ventricle.
- the next step is to retrieve the failing exchangeable component 30 (Figure 6C). This is achieved through a magnetic engagement between the retrieval module 115 and the failing exchangeable component 30 and the disengagement of the failing exchangeable component 30 and the permanent component 20. Where an electromagnet is used, the failing exchangeable component 30 is disengaged from contact with the permanent component 20 by increasing the magnetic attraction from the electromagnet over and above the outward radial forces on the failing exchangeable component 30. As the failing exchangeable component 30 is disengaged from the permanent component 20, it preferably crimps or collapses as it is pulled towards the retrieval module 115 due to the magnetic force of the retrieval module 115.
- the failing exchangeable component 30 can be withdrawn from the aortic root 10 into the aorta ( Figure 6D). It is preferable to space the deployment module 120 and the retrieval module 115 such that the withdrawal of the retrieval module 115 simultaneously positions the replacement exchangeable component 40 in the correct position within the permanent component 20.
- the deployment sheath 42 is withdrawn from the replacement exchangeable component 40 and deployed in the manner described above.
- the replacement exchangeable component 40 may be designed not to make contact with native tissue as this minimises tissue growth onto the replacement exchangeable component 40, which is undesirable.
- the failing exchangeable component 30 can be withdrawn into the retrieval sheath 50 to reduce its cross-sectional profile (Figure 6G).
- the reduced cross-sectional profile allows the failing exchangeable component 30 to be withdrawn through the vascular access sheath (not shown). It would be apparent that it is not necessary for the failing exchangeable component 30 to be fully crimped before it could be withdrawn into the retrieval sheath 50.
- the tapered profile of the conical portion 54 helps to reduce the cross- sectional profile of the failing exchangeable component 30 as it is withdrawn. In some cases, the failing exchangeable component 30 is crushed during the retrieval process.
- the catheter 100 is removed from the patient ( Figure 6H). While the above method includes the deployment of a replacement exchangeable component 40, it would be apparent that the steps in relation to the deployment of the replacement exchangeable component 40 are not essential to the steps in relation to the retrieval of the failing exchangeable component 30. Similarly, if a catheter having only a deployment module 120 is to be used, the steps in relation to retrieving the failing exchangeable component 30 can be omitted.
- the present disclosure provides a method of retrieving a replacement heart valve component from within a blood vessel, including the steps of introducing a catheter 100 having a retrieval module 115 into the blood vessel, positioning the retrieval module 115 within the aortic root 10 to retrieve a failing exchangeable component 30, retrieving the failing exchangeable component 30 by a magnetic engagement between the retrieval module 115 and the failing exchangeable component 30. Withdrawing the catheter from the blood vessel with the failing exchangeable component 30 secured to the retrieval module 115.
- the catheter 100 has been described in relation to retrieving a replacement heart valve component from within an aortic root 10, it would be apparent the presently described catheter 100 could be used to retrieve components within any of the valves of the heart, such as the mitral valve, the tricuspid valve, or the pulmonary valve.
- the magnetic coupling between the catheter and the replacement heart valve component may be used to retrieve any cardiovascular device from within a blood vessel, such as a stent.
- the catheter may have a retrieval module configured to magnetically engage a stent within the blood vessel, to disengage the stent from the blood vessel.
- the self-expanding frames described herein are similar to those used in stents.
- the heart valve frame may be considered equivalent to a stent frame, with the skirt and leaflets attached thereto.
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Surgical Instruments (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2315081.6A GB2619876A (en) | 2021-03-04 | 2022-03-03 | A catheter |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2103033.3A GB202103033D0 (en) | 2021-03-04 | 2021-03-04 | A catheter |
GB2103033.3 | 2021-03-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022185063A1 true WO2022185063A1 (en) | 2022-09-09 |
Family
ID=75439101
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2022/050562 WO2022185063A1 (en) | 2021-03-04 | 2022-03-03 | A catheter |
Country Status (2)
Country | Link |
---|---|
GB (2) | GB202103033D0 (en) |
WO (1) | WO2022185063A1 (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050131423A1 (en) * | 2002-05-23 | 2005-06-16 | Daniel Yachia | Medical device having an unravelable portion |
US20150073533A1 (en) * | 2009-04-16 | 2015-03-12 | Cvdevices, Llc | Linked deflection devices, systems and methods for the prevention of stroke |
EP2601910B1 (en) * | 2002-08-15 | 2018-09-19 | Cook Medical Technologies LLC | Implantable vascular device |
US20190269535A1 (en) * | 2018-03-05 | 2019-09-05 | Regents Of The University Of Minnesota | Central airway stent removal device and related systems and methods |
WO2020106827A1 (en) * | 2018-11-21 | 2020-05-28 | Edwards Lifesciences Corporation | Heart valve sealing devices, delivery devices therefor, and retrieval devices |
US20200368006A1 (en) * | 2019-05-20 | 2020-11-26 | St. Jude Medical, Cardiology Division, Inc. | TAVR Embolic Protection via Debris Capture or Deflection |
US20200397558A1 (en) * | 2016-04-11 | 2020-12-24 | Baylor College Of Medicine | Removable ureteral stents and methods of use of the same |
-
2021
- 2021-03-04 GB GBGB2103033.3A patent/GB202103033D0/en not_active Ceased
-
2022
- 2022-03-03 GB GB2315081.6A patent/GB2619876A/en active Pending
- 2022-03-03 WO PCT/GB2022/050562 patent/WO2022185063A1/en active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050131423A1 (en) * | 2002-05-23 | 2005-06-16 | Daniel Yachia | Medical device having an unravelable portion |
EP2601910B1 (en) * | 2002-08-15 | 2018-09-19 | Cook Medical Technologies LLC | Implantable vascular device |
US20150073533A1 (en) * | 2009-04-16 | 2015-03-12 | Cvdevices, Llc | Linked deflection devices, systems and methods for the prevention of stroke |
US20200397558A1 (en) * | 2016-04-11 | 2020-12-24 | Baylor College Of Medicine | Removable ureteral stents and methods of use of the same |
US20190269535A1 (en) * | 2018-03-05 | 2019-09-05 | Regents Of The University Of Minnesota | Central airway stent removal device and related systems and methods |
WO2020106827A1 (en) * | 2018-11-21 | 2020-05-28 | Edwards Lifesciences Corporation | Heart valve sealing devices, delivery devices therefor, and retrieval devices |
US20200368006A1 (en) * | 2019-05-20 | 2020-11-26 | St. Jude Medical, Cardiology Division, Inc. | TAVR Embolic Protection via Debris Capture or Deflection |
Also Published As
Publication number | Publication date |
---|---|
GB202315081D0 (en) | 2023-11-15 |
GB202103033D0 (en) | 2021-04-21 |
GB2619876A (en) | 2023-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210361425A1 (en) | Delivery Systems And Methods Of Implantation For Prosthetic Heart Valves | |
US10772726B2 (en) | Biological valve treatment device with pushing member of the valve | |
EP3454795B1 (en) | Heart valve prosthesis delivery system for delivery of heart valve prosthesis with introducer sheath and loading system | |
CN107635513B (en) | Implant tube, system for implanting the same and method for setting and pushing the same | |
EP3949905B1 (en) | Catheter assembly with valve crimping accessories | |
US9149358B2 (en) | Delivery systems for prosthetic heart valves | |
EP3466373B1 (en) | Replacement prosthetic heart valve system | |
US20180133011A1 (en) | Implant for treating a biological valve | |
EP2526895B1 (en) | Repositionable heart valve | |
EP3290004B1 (en) | Quick-connect prosthetic heart valve | |
JP5811419B2 (en) | Prosthetic device crimp device and catheter device provided with prosthetic device holder | |
EP3603575B1 (en) | Transcatheter prosthetic heart valve delivery system with controlled expansion of prosthetic heart valve | |
US6682558B2 (en) | Delivery system for a stentless valve bioprosthesis | |
EP3429508B1 (en) | Transcatheter stented prosthetic heart valve delivery devices with primary and secondary release mechanisms | |
US8414640B2 (en) | Delivery system ejection component and method | |
US20090287290A1 (en) | Delivery Systems and Methods of Implantation for Prosthetic Heart Valves | |
US8663302B2 (en) | Delivery system ejection component and method | |
WO2015123607A2 (en) | Temporary sub-valvular check valve | |
WO2022185063A1 (en) | A catheter | |
US20220047386A1 (en) | Prosthesis connecting device | |
EP4085875B1 (en) | Method of implant loading | |
WO2023214253A1 (en) | Transcatheter delivery device having flexible capsule |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22708594 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 202315081 Country of ref document: GB Kind code of ref document: A Free format text: PCT FILING DATE = 20220303 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 22708594 Country of ref document: EP Kind code of ref document: A1 |